Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Capital Expenditures (2016 - 2025)

AC Immune has reported Capital Expenditures over the past 10 years, most recently at -$133875.2 for Q4 2025.

  • Quarterly Capital Expenditures fell 30.31% to -$133875.2 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 million through Dec 2025, down 60.96% year-over-year, with the annual reading at -$1.1 million for FY2025, 71.26% down from the prior year.
  • Capital Expenditures was -$133875.2 for Q4 2025 at AC Immune, down from -$72506.4 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $4.9 million in Q4 2021 and troughed at -$873786.7 in Q1 2021.
  • The 5-year median for Capital Expenditures is -$205646.8 (2023), against an average of $74110.8.
  • Year-over-year, Capital Expenditures soared 76.76% in 2022 and then plummeted 499.17% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $4.9 million in 2021, then tumbled by 48.71% to $2.5 million in 2022, then crashed by 107.4% to -$187140.8 in 2023, then soared by 45.1% to -$102737.0 in 2024, then tumbled by 30.31% to -$133875.2 in 2025.
  • Per Business Quant, the three most recent readings for ACIU's Capital Expenditures are -$133875.2 (Q4 2025), -$72506.4 (Q3 2025), and -$450543.1 (Q2 2025).